Revenue treatment of aborted IPO costs, section 10B receipts, and hedging losses under export business principles.

IPO expenditure for an aborted public issue was treated as revenue expenditure where no asset or enduring benefit arose, while foreign exchange differences and excess provision written back were held to have a direct nexus with the operations of an export-oriented undertaking for section 10B purposes. Product development expenses were dealt with as recurring business expenditure, with deferred revenue treatment not accepted on the facts. The discussion also records that disallowance under section 14A read with Rule 8D is confined to the exempt income earned in the year, and that loss on settlement of forward foreign exchange contracts entered into for export hedging is a normal business loss, not a speculation loss.

---

---

Issues: (i) whether IPO expenditure incurred for an aborted public issue was capital or revenue expenditure; (ii) whether foreign exchange difference and excess provision written back were eligible for deduction under section 10B; (iii) whether product development expenses could be deferred and disallowed as capital in nature; (iv) whether disallowance under section 14A read with Rule 8D could exceed exempt income; and (v) whether loss on settlement of forward foreign exchange contracts was speculation loss or normal business loss.

Issue (i): whether IPO expenditure incurred for an aborted public issue was capital or revenue expenditure.

Analysis: The expenditure was incurred for a proposed IPO that was ultimately abandoned. No asset came into existence and no enduring benefit accrued to the assessee. The capital-expansion cases relied upon by the Revenue were distinguished because those matters involved actual enlargement of capital base, whereas the present expenditure related to a failed issue.

Conclusion: The IPO expenditure was allowable as revenue expenditure under section 37(1) and the disallowance was deleted in favour of the assessee.

Issue (ii): whether foreign exchange difference and excess provision written back were eligible for deduction under section 10B.

Analysis: The amounts arose in the normal course of the export-oriented undertaking's business and had a direct nexus with the sale and purchase operations of the eligible unit. Though shown as other income, they were held to be derived from the export activity of the undertaking and not to be divorced from its business operations. The direct nexus test was applied on the peculiar facts of the case.

Conclusion: The assessee was held eligible for deduction under section 10B on these receipts and the disallowance was deleted in favour of the assessee.

Issue (iii): whether product development expenses could be deferred and disallowed as capital in nature.

Analysis: The issue was treated as a recurring legacy matter already decided in earlier years in favour of the assessee. Following the earlier binding and consistently applied view, the expenditure was treated as business expenditure and the concept of deferred revenue expenditure was not accepted on the facts.

Conclusion: The deletion of the addition on account of product development expenses was upheld and the Revenue's ground failed.

Issue (iv): whether disallowance under section 14A read with Rule 8D could exceed exempt income.

Analysis: The Tribunal applied the settled principle that the disallowance under section 14A cannot be more than the exempt income earned during the relevant year. The Revenue's reliance on the mechanical application of Rule 8D did not displace this ceiling, and the assessee's relief was confined to that limit.

Conclusion: The disallowance under section 14A was restricted to exempt income and the Revenue's challenge was rejected.

Issue (v): whether loss on settlement of forward foreign exchange contracts was speculation loss or normal business loss.

Analysis: The forward contracts were entered into in the course of the assessee's export business to hedge foreign exchange exposure. Such hedging transactions were held to be integral to the business and not speculative, and the contrary factual characterisation was not accepted.

Conclusion: The loss on forward contracts was held to be a normal business loss and not speculation loss, and the Revenue's ground was rejected.

Final Conclusion: The assessee succeeded on the IPO expenditure and section 10B issues, while the Revenue failed on the product development expense and forward contract loss issues; the section 14A relief was confined by the exempt-income ceiling, resulting in a mixed outcome with the assessee obtaining substantial relief overall.

Ratio Decidendi: Expenditure on an abandoned capital-raising proposal remains revenue in character if no asset or enduring benefit emerges, receipts having a direct nexus with the operations of an export-oriented undertaking may qualify as derived income for section 10B, section 14A disallowance cannot exceed exempt income, and bona fide hedging losses on forward foreign exchange contracts are not speculation losses.

---